Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2020Journal of Nursing and Midwifery SciencesOpen Access

A mobile app for DASH diet education significantly reduced systolic blood pressure (144.65 vs 161.09 mmHg, p=0.0001) compared to usual care in patients with hypertension.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Failure to adhere to drug therapy in patients with high blood pressure can endanger their lives, prompting evaluation of a smartphone-based medication reminder application.

Does a mobile phone education application based on self-efficacy and the DASH diet improve blood pressure and self-efficacy in patients with hypertension?

Population

78 patients with essential hypertension

Comparison

Smartphone medication reminder application (DaroYab 2.1.0) vs routine care

Design

Clinical trial study

Follow-up

3 months

Key result

A mobile app for DASH diet education significantly reduced systolic blood pressure (144.65 vs 161.09 mmHg, p=0.0001) compared to usual care in patients with hypertension.

Authors

SHShahin HeidariSTSajede Mohammadi TorkabadTBTayebeh Negahban Bonabi

Discussion

Loading...

Member takes

Overview

App may boost adherence in hypertension; leaves open need for larger trials on clinical outcomes.

Study Design

Type

RCT (n=88)

Randomization

Computer-generated random numbers

Structured PICO

Does a mobile phone education application based on self-efficacy and the DASH diet improve blood pressure and self-efficacy in patients with hypertension?

P
Population
88 overweight or obese adults aged 30 to 69 years with established hypertension on anti-hypertensive medication, followed for 12 weeks.
I
Intervention
Android-based offline mobile application providing DASH diet recommendations based on self-efficacy, including short educational videos and weekly reminders via text/calls, plus usual health-related recommendations, for 12 weeks.
C
Comparator
Usual health-related recommendations in a public health care center for 12 weeks.
O
Outcome
Systolic and diastolic blood pressure, self-efficacy, and adherence to the DASH diet at 12 weeks.surrogate

Main Result

Absolute Event Rate: 144.65% vs 161.09%

p-value: p=0.0001

A smartphone-based educational application focusing on the DASH diet and self-efficacy significantly reduced systolic and diastolic blood pressure in patients with hypertension.

Limitations

  • Small sample size
  • Did not consider differences between ethnicities
  • Failure to measure the metabolic profile
  • Application was designed only for Android devices
  • Included only people in Khuzestan province, limiting generalizability

Cite This Study

Heidari et al. (2020) conducted an RCT in Essential hypertension (n=88). Mobile app for DASH diet education based on self-efficacy vs. Usual health care was evaluated on Systolic blood pressure (mmHg) at 12 weeks (p=0.0001). A mobile app for DASH diet education significantly reduced systolic blood pressure (144.65 vs 161.09 mmHg, p=0.0001) compared to usual care in patients with hypertension.

synapsesocial.com/papers/6a75edacb1c5cc4eb2b1d533https://doi.org/10.4103/jnms.jnms_16_20
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mobilizing Your Medications: An Automated Medication Reminder Application for Mobile Phones and Hypertension Medication Adherence in a High-Risk Urban Population2013 · 127 citations
  2. 2Specific hypertension smartphone application to improve medication adherence in hypertension: a cluster-randomized trial2018 · 149 citations
  3. 3Improving treatment adherence in hypertension patients: a randomised controlled trial2025 · 1 citations
  4. 4The Effect of the Mobile ‘Blood Pressure Management Application’ on Hypertension Self-Management Enhancement: A Randomized Controlled Trial2021 · 1 citations
  5. 5The Effect of the Mobile ‘Blood Pressure Management Application’ on Hypertension Self-Management Enhancement: A Randomized Controlled Trial2020